Evidence map›Paper›PMID 32153556›Full record

ArticleFrontiers in immunology2020

Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD

John R Moffett, Peethambaran Arun, Narayanan Puthillathu, Ranjini Vengilote, John A Ives, Abdulla A-B Badawy, Aryan M Namboodiri

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. The spleen-brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

John R MoffettDepartments of Anatomy, Physiology and Genetics and Neuroscience Program, Uniformed Services University Medical School, Bethesda, MD, United States.
Peethambaran ArunDepartments of Anatomy, Physiology and Genetics and Neuroscience Program, Uniformed Services University Medical School, Bethesda, MD, United States.
Narayanan PuthillathuDepartments of Anatomy, Physiology and Genetics and Neuroscience Program, Uniformed Services University Medical School, Bethesda, MD, United States.
Ranjini VengiloteDepartments of Anatomy, Physiology and Genetics and Neuroscience Program, Uniformed Services University Medical School, Bethesda, MD, United States.
John A IvesThe Center for Brain, Mind, and Healing, Samueli Institute, Alexandria, VA, United States.
Abdulla A-B BadawyIndependent Consultant, Cardiff, United Kingdom.
Aryan M NamboodiriDepartments of Anatomy, Physiology and Genetics and Neuroscience Program, Uniformed Services University Medical School, Bethesda, MD, United States.
Uniformed Services University of the Health Sciences · USSamueli Institute · US

Funding

Acetate Supplementation as a therapeutic strategy for Canavan diseaseR21NS084206 · NINDS · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI NAMBOODIRI, ARYAN MANGALAM · 2014 to 2015
$418k
NINDS NIH HHS R21 NS084206
6 · The paper itself

Abstract

Quinolinate (Quin) is a classic example of a biochemical double-edged sword, acting as both essential metabolite and potent neurotoxin. Quin is an important metabolite in the kynurenine pathway of tryptophan catabolism leading to the

Indexed as

AnimalsBiomarkersCell MovementGerbillinaeHippocampusHSP90 Heat-Shock ProteinsImmunityIndoleamine-Pyrrole 2,3,-DioxygenaseInflammationKynurenineLipopolysaccharidesLiverMaleMiceMice, Inbred C57BLNADBiomarkersHSP90 Heat-Shock ProteinsIndoleamine-Pyrrole 2,3,-DioxygenaseKynurenineLipopolysaccharidesNADPokeweed MitogensPoly(ADP-ribose) PolymerasesQuinolinic AcidTryptophancell motilityERM proteinsfoam cellsHSP90indoleamine 2,3-dioxygenasekynurenine pathwayPARPquinolinic acid

Identifiers

PMID32153556
PMCPMC7047773
OpenAlexW3007394158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.